Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
OncLive Global Expo
Giants of Cancer Care
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
Related Articles
Renowned Urologic Oncologist Selected to Lead Urology/Bladder Cancer Program at NYU Langone Health
Pembrolizumab Shows Promise for Unmet Need in NMIBC
Shum Sheds Light on Oncogene-Driven NSCLC Treatment Options
Related Videos
Dr. Balar on Next Steps of the KEYNOTE-057 Trial in NMIBC
Dr. Polsky on Using ctDNA as a Biomarker for Melanoma
Dr. Esteva on the Prevalence of Precision Medicine in Breast Cancer
OncologyLive > Vol. 20/No. 6 >

Perlmutter Earns NCI Comprehensive Cancer Center Designation

Published: Friday, Mar 15, 2019
Benjamin G. Neel, MD, PhD

Benjamin G. Neel, MD, PhD

The National Cancer Institute (NCI) has designated NYU Langone Health’s Laura and Isaac Perlmutter Cancer Center as a Comprehensive Cancer Center, the highest rank awarded by the NCI. Perlmutter joins an elite group of 50 cancer centers across the country that have earned this distinction.
... to read the full story
To Read the Full Story
REGISTER
LOG IN

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
 
x